Biotechnology Stockmarket Biotech

Biotech Stock Update: Keryx Falls after Ferric Citrate’s Tests

The FDA has approved Keryx Biopharmaceuticals, Inc’s (KERX) ferric citrate to control serum phosphorus levels in patients suffering from chronic kidney disease (CKD) on dialysis. However, the news adversely affected the stock price, which fell more than 5%, as the drug was approved with several warnings. Ferric citrate is not recommended for patients with an…

Read More

Stock in News: Microsoft (NASDAQ MSFT) Goes into Cloud

Wednesday, before the opening day of the International Broadcasting Convention (IBC), Microsoft Corp (Nasdaq MSFT) announced new cloud-first media services, including HD-quality live streaming that supports today’s most popular devices and platforms, end-to-end content protection capabilities, and a new service that simplifies the indexing of audio and video content and makes it easier to search….

Read More

Stock Highlights: Gerdau (NYSE:GGB), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), TriNet Group, Inc. (NYSE:TNET), Harley-Davidson, Inc. (NYSE:HOG), Credit Acceptance Corp. (NASDAQ:CACC)

Gerdau SA (NYSE:GGB) has earned credit rating from Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Gerdau S.A. (NYSE:GGB) belongs to Basic Materials sector. Its net profit margin is…

Read More
Home